Oramed Pharmaceuticals Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics, Inc. |
$5.45 | $229.34 M | -7.57 | 9 | $0 |
ARDX
Ardelyx, Inc. |
$4.97 | $1.51 B | -23.04 | 267 | $124.46 M |
AVRO
AVROBIO, Inc. |
$48.52 | $68.24 M | 2.2 | 13 | $0 |
BLRX
BioLineRx Ltd. |
$0.27 | $55.34 M | -0.87 | 79 | $4.80 M |
CKPT
Checkpoint Therapeutics, Inc. |
$3.65 | $68.32 M | -0.72 | 23 | $103,000 |
CRVS
Corvus Pharmaceuticals, Inc. |
$5.83 | $126.98 M | -3.98 | 28 | $0 |
CWBR
CohBar, Inc. |
$0.41 | $2.33 M | -0.18 | 9 | $0 |
CYTO
Altamira Therapeutics Ltd. |
$0.30 | $3.20 M | -0.09 | 10 | $0 |
ELEV
Elevation Oncology, Inc. |
$0.66 | $192.87 M | -4.15 | 29 | $0 |
ENVB
Enveric Biosciences, Inc. |
$0.40 | $5.89 M | -0.12 | 7 | $0 |
GMDA
Gamida Cell Ltd. |
$0.03 | $4.34 M | -0.04 | 143 | $1.78 M |
HEPA
Hepion Pharmaceuticals, Inc. |
$0.64 | $6.02 M | -0.12 | 22 | $0 |
IBRX
ImmunityBio, Inc. |
$2.81 | $4.22 B | -5.65 | 672 | $622,000 |
IMMX
Immix Biopharma, Inc. |
$2.35 | $53.62 M | -2.18 | 14 | $0 |
INZY
Inozyme Pharma, Inc. |
$3.07 | $286.39 M | -3.43 | 59 | $0 |
LPTX
Leap Therapeutics, Inc. |
$3.35 | $85.71 M | -1.79 | 54 | $0 |
LXRX
Lexicon Pharmaceuticals, Inc. |
$0.79 | $632.61 M | -2.11 | 285 | $1.20 M |
MCRB
Seres Therapeutics, Inc. |
$0.91 | $92.99 M | -1.04 | 233 | $126.33 M |
MREO
Mereo BioPharma Group plc |
$3.73 | $479.72 M | -22.8 | 33 | $10.00 M |
OCEA
Ocean Biomedical, Inc. |
$0.73 | $50.07 M | -0.48 | 9 | $0 |
PALI
Palisade Bio, Inc. |
$1.90 | $4.28 M | -0.19 | 9 | $250,000 |
PLX
Protalix BioTherapeutics, Inc. |
$2.11 | $82.11 M | 14 | 208 | $65.49 M |
TERN
Terns Pharmaceuticals, Inc. |
$5.75 | $462.44 M | -5.67 | 66 | $0 |
XFOR
X4 Pharmaceuticals, Inc. |
$0.74 | $169.62 M | -1.51 | 127 | $0 |
ZURA
Zura Bio Limited |
$2.58 | $255.37 M | 6.17 | 14 | $0 |